Specialities

Nephrology

Hypertension and nephrology

NOVEMBER 01, 2021

[Unattended automated office blood pressure measurement versus classic office automated blood pressure measurement in a hypertension outpatient clinic]

LÉGRÁDY Péter, FEJES Imola, CZOMBOS András, ÁBRAHÁM György

[Accurate measurement of blood pressure is a fundamental prerequisite requirement for an appropriate management of arterial hypertension. In order to eliminate the well-known limitations of classic office blood pressure measurements, the so-called unattended automatic office blood pressure measurement method can be a solution. In 52 patients arriving for regular followup into one of the Hypertension Outpatinet Clinic of the Nephrology-Hypertension Center of the University of Szeged 3-3 blood... tovább »

Hypertension and nephrology

NOVEMBER 01, 2021

[Beyond the diagnosis – the value of renal biopsy in clinical practice through the example of two glomerular diseases]

DOBI Deján

[In this review, the publications that established the value of renal biopsy in nephrology are referenced, the pathomechanism of lupus nephritis (LN) and IgA glomerulonephritis (IgAGN) is briefly summarized, and a detailed account is given on the previous and currently accepted classification systems of LN and IgAGN and on the prognostic relevance of these systems. ]

Hypertension and nephrology

OCTOBER 25, 2021

[Roxadustat is not dialyzed in chronic kidney disease to treat your anemia]

EVGENY Shutov, WŁADYSŁAW Sułowicz, CIRO Esposito, AVTANDIL Tataradze, BRANISLAV Andric, MICHAEL Reusch, UDAYA Valluri, NADA Dimkovic

Clinical Neuroscience

SEPTEMBER 30, 2021

[Treatment and new evidences in neuromyelitis optica spectrum disorder ]

ILLÉS Zsolt

[Treatment and new evidences in neuromyelitis optica spectrum disorder Illés Zs, MD, PhD Ideggyogy Sz 2021;74(9–10):309–321. Neuromyelitis optica spectrum disorder (NMOSD) is associated with antibodies against AQP4 in about 80% of the cases. In about one-fourth of seronegative cases, antibodies against the MOG protein are present in the serum (MOG-antibody associated disease, MOGAD). This article discusses off-label azathioprine and mycophenolate mofetil in the treatment of NMOSD and... tovább »

Hypertension and nephrology

SEPTEMBER 13, 2021

[Membranous glomerulopathy: two cases]

BÓDI Brigitta, FEJES Réka, KARDOS Magdolna, DEÁK György

[Summary – Membranous glomerulopathy (MGP) is the most frequent cause of nephrotic syndrome in adults. It is classified as a primary autoimmune disease or secondary MGP due to malignancies, autoimmune diseases, infections or adverse drug reactions. Here we present two cases of MGP.]

Hypertension and nephrology

SEPTEMBER 13, 2021

[Lipid-lowering treatment in chronic kidney disease in light of new studies and recommendations]

MÁTYUS János

[Summary – Chronic kidney disease (CKD), which affects 10-14% of the population, dramatically increases the incidence and severity of cardiovascular (CV) disease, leading to death in the majority of patients before kidney replacement therapy. The current CV risk scorecards in CKD significantly underestimate the real risk and are therefore not applicable. For CV risk assessment it is recommended to use the combined GFR/proteinuria table also, which is used for CKD classification, was also... tovább »